CHEMOURS ($CC) posted quarterly earnings results for Q1 2026 on Tuesday, May 5th. The company reported earnings of $0.05 per share, beating estimates of -$0.05 by $0.10. The company also reported revenue of $1,381,000,000, missing estimates of $1,428,232,329 by $-47,232,329.
Stock price change since market close: -2.69%
You can see Quiver Quantitative's $CC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CHEMOURS Hedge Fund Activity
We have seen 174 institutional investors add shares of CHEMOURS stock to their portfolio, and 206 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 2,252,307 shares (-50.1%) from their portfolio in Q4 2025, for an estimated $26,554,699
- LUMINUS MANAGEMENT LLC removed 1,407,020 shares (-79.7%) from their portfolio in Q4 2025, for an estimated $16,588,765
- MARSHALL WACE, LLP removed 1,254,855 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $14,794,740
- AMERICAN CENTURY COMPANIES INC added 1,237,283 shares (+52.0%) to their portfolio in Q4 2025, for an estimated $14,587,566
- WOLF HILL CAPITAL MANAGEMENT, LP removed 1,074,837 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $12,672,328
- SONA ASSET MANAGEMENT (US) LLC added 1,055,000 shares (+176.9%) to their portfolio in Q4 2025, for an estimated $12,438,450
- SCOPIA CAPITAL MANAGEMENT LP removed 1,013,285 shares (-35.1%) from their portfolio in Q4 2025, for an estimated $11,946,630
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
CHEMOURS Analyst Ratings
Wall Street analysts have issued reports on $CC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 11/11/2025
- RBC Capital issued a "Outperform" rating on 11/10/2025
- Truist Securities issued a "Buy" rating on 11/10/2025
To track analyst ratings and price targets for CHEMOURS, check out Quiver Quantitative's $CC forecast page.
CHEMOURS Price Targets
Multiple analysts have issued price targets for $CC recently. We have seen 8 analysts offer price targets for $CC in the last 6 months, with a median target of $18.5.
Here are some recent targets:
- Peter Osterland from Truist Securities set a target price of $30.0 on 04/28/2026
- Joshua Spector from UBS set a target price of $29.0 on 04/09/2026
- John Roberts from Mizuho set a target price of $21.0 on 03/05/2026
- Duffy Fischer from Goldman Sachs set a target price of $18.0 on 02/25/2026
- Vincent Andrews from Morgan Stanley set a target price of $17.0 on 02/23/2026
- John McNulty from BMO Capital set a target price of $19.0 on 02/23/2026
- Jeffrey Zekauskas from JP Morgan set a target price of $17.0 on 02/23/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
